Senstream

Senstream operates at the intersection of wearable biosensing, digital health, and research instrumentation. Its differentiation is centered on combining a ring form factor with research-oriented signal quality and raw-data access, rather than positioning the product only as a consumer wellness tracker. The stated sensor set—EDA, ECG, PPG, temperature, and motion—supports multimodal physiological studies, while BIOPAC integration may reduce friction for researchers already using laboratory data-acquisition systems. The company’s mobile- and cloud-native architecture also allows studies to extend beyond fixed laboratory environments. Relative to general-purpose consumer wearables, Senstream’s stated emphasis on lab-grade data, research workflows, and access to underlying signals is the clearest positioning distinction. With an estimated workforce of one to ten people and no disclosed funding or valuation, Senstream appears to remain a specialized, early-scale participant in research-focused biowearables.

Senstream’s trajectory appears to have developed from a focused hardware concept into a broader research-data platform. Founded in 2013, the company is associated with a Research Ring that combines multiple biosignal sensors with motion and temperature capture. Its product description goes beyond hardware, emphasizing mobile and cloud functionality, raw physiological data access, and BIOPAC integration. Those capabilities represent a potential inflection point because they address both data collection and downstream research workflows, rather than treating the wearable as a standalone device. The company is currently represented by one featured employee and an estimated workforce of one to ten, with no disclosed financing rounds, investors, valuation, hiring program, or revenue data. Future growth assessment would require evidence on deployments, research customers, regulatory status, manufacturing volume, recurring software usage, and additional personnel or capital commitments.